Viral Diseases Tester Virax Biolabs Prices Upsized US$6.75 Million IPO

Biopharmaceutical company Virax Biolabs Group Limited recently increased its initial public offering size as it applies for a Nasdaq Capital Market listing. The firm is now looking to raise US$6.75 million.

The offering consists of 1.35 million common shares, up from the previously announced 1.2 million, selling at US$5.00 per share. The company targets to trade on the Nasdaq market under the symbol “VRAX”.

Boustead Securities acts as the sole bookrunner for the said offering. The underwriters were granted a 45-day over-allotment option to purchase additional 202,500 shares at the same IPO price.

Net proceeds from the offering are expected to be used for research & development, obtaining product certification approvals, expanding staff & payroll, marketing & advertising, working capital, operating expenses, inventory purchases, and regulatory & compliance work.

The UK-based biotech company focuses on developing T-cell testing as a method to detect one’s risk to major global viral threats through immunology profiling. The firm recently received ethical approval for its current study involving its Virax Immune COVID-19 test kit that bases its detection of viral immunity on T-cells instead of antibodies like most other kits.


Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

When 4% of Global Copper Disappears Overnight | David Gower – Emerita Resources

Mining M&A: Gold X2 Acquires Kesselrun Resources

They Said Oil Was Dead. They Were Wrong. | Michael Judson – Record Resources

Recommended

Steadright Secures Two Additional Exploration Licenses For Flagship Project

First Majestic Posts Record Quarterly Silver Production In Q3

Related News

Investment Firm-Backed SPAC Sound Point Acquisition I Prices Upsized US$225 Million IPO

Special purpose acquisition company Sound Point Acquisition Corp I (Nasdaq: SPCMU) started trading publicly on...

Wednesday, March 2, 2022, 02:23:00 PM

Tech SPAC Athena Technology Acquisition II Looks To Raise US$250 Million In IPO

Blank check company Athena Technology Acquisition Corp. II (NYSE: ATEK.U) went public today on the...

Friday, December 10, 2021, 02:11:00 PM

$BABY: Weak Demand For IPO Caused Debuting Nasdaq Stock To Fail On Trading Day

PishPosh, a small baby-goods shop that wanted to list under the ticker BABY, had its...

Saturday, March 11, 2023, 01:42:00 PM

Coinbase: The IPO Deep Dive

Coinbase Global (NASDAQ: COIN) is one of the hottest deals coming to market in 2021...

Tuesday, April 13, 2021, 01:30:00 PM

Foodservice SPAC Banyan Acquisition Aims To Conduct A US$210 Million IPO

Blank check company Banyan Acquisition Corporation (NYSE: BYN.U) is looking to raise US$210 million for...

Thursday, January 20, 2022, 02:24:00 PM